BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Aizpurua-olaizola O, Elezgarai I, Rico-barrio I, Zarandona I, Etxebarria N, Usobiaga A. Targeting the endocannabinoid system: future therapeutic strategies. Drug Discovery Today 2017;22:105-10. [DOI: 10.1016/j.drudis.2016.08.005] [Cited by in Crossref: 65] [Cited by in F6Publishing: 61] [Article Influence: 13.0] [Reference Citation Analysis]
Number Citing Articles
1 Leimuranta P, Khiroug L, Giniatullin R. Emerging Role of (Endo)Cannabinoids in Migraine. Front Pharmacol 2018;9:420. [PMID: 29740328 DOI: 10.3389/fphar.2018.00420] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
2 Koenig AM, Gao W, Umlauft M, Schury K, Reister F, Kirschbaum C, Karabatsiakis A, Kolassa I. Altered hair endocannabinoid levels in mothers with childhood maltreatment and their newborns. Biological Psychology 2018;135:93-101. [DOI: 10.1016/j.biopsycho.2018.03.006] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
3 Gallego Villarejo L, Bachmann L, Marks D, Brachthäuser M, Geidies A, Müller T. Role of Intracellular Amyloid β as Pathway Modulator, Biomarker, and Therapy Target. Int J Mol Sci 2022;23:4656. [PMID: 35563046 DOI: 10.3390/ijms23094656] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Yu Y, Nguyen DT, Jiang J. G protein-coupled receptors in acquired epilepsy: Druggability and translatability. Prog Neurobiol 2019;183:101682. [PMID: 31454545 DOI: 10.1016/j.pneurobio.2019.101682] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
5 Garai S, Schaffer PC, Laprairie RB, Janero DR, Pertwee RG, Straiker A, Thakur GA. Design, synthesis, and pharmacological profiling of cannabinoid 1 receptor allosteric modulators: Preclinical efficacy of C2-group GAT211 congeners for reducing intraocular pressure. Bioorg Med Chem 2021;50:116421. [PMID: 34634617 DOI: 10.1016/j.bmc.2021.116421] [Reference Citation Analysis]
6 Alves VL, Gonçalves JL, Aguiar J, Teixeira HM, Câmara JS. The synthetic cannabinoids phenomenon: from structure to toxicological properties. A review. Crit Rev Toxicol 2020;50:359-82. [PMID: 32530350 DOI: 10.1080/10408444.2020.1762539] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 6.5] [Reference Citation Analysis]
7 Ramírez A, Viveros JM. Brewing with Cannabis sativa vs. Humulus lupulus : a review. J Inst Brew 2021;127:201-9. [DOI: 10.1002/jib.654] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Hor MKS, Dzwonkowski M, Kolodziejczyk T, Muir L, Dubchak N, Hochroth S, Patel B, Wu A, Knight S, Smith G, Patel U, Remley Q, Hummer C. Cannabinoids in Gastrointestinal Disorders. In: Finn K, editor. Cannabis in Medicine. Cham: Springer International Publishing; 2020. pp. 415-51. [DOI: 10.1007/978-3-030-45968-0_17] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Stasiulewicz A, Znajdek K, Grudzień M, Pawiński T, Sulkowska AJI. A Guide to Targeting the Endocannabinoid System in Drug Design. Int J Mol Sci 2020;21:E2778. [PMID: 32316328 DOI: 10.3390/ijms21082778] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 15.0] [Reference Citation Analysis]
10 Belinskaia DA, Belinskaia MA, Barygin OI, Vanchakova NP, Shestakova NN. Psychotropic Drugs for the Management of Chronic Pain and Itch. Pharmaceuticals (Basel) 2019;12:E99. [PMID: 31238561 DOI: 10.3390/ph12020099] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 4.7] [Reference Citation Analysis]
11 Stastnik O, Pavlata L, Mrkvicova E. The Milk Thistle Seed Cakes and Hempseed Cakes are Potential Feed for Poultry. Animals (Basel) 2020;10:E1384. [PMID: 32785057 DOI: 10.3390/ani10081384] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
12 Pugazhendhi A, Suganthy N, Chau TP, Sharma A, Unpaprom Y, Ramaraj R, Karuppusamy I, Brindhadevi K. Cannabinoids as anticancer and neuroprotective drugs: Structural insights and pharmacological interactions—A review. Process Biochemistry 2021;111:9-31. [DOI: 10.1016/j.procbio.2021.08.025] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Boyer C, Cussonneau L, Brun C, Deval C, Pais de Barros JP, Chanon S, Bernoud-Hubac N, Daira P, Evans AL, Arnemo JM, Swenson JE, Gauquelin-Koch G, Simon C, Blanc S, Combaret L, Bertile F, Lefai E. Specific shifts in the endocannabinoid system in hibernating brown bears. Front Zool 2020;17:35. [PMID: 33292302 DOI: 10.1186/s12983-020-00380-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Correia-Sá I, Paiva A, Carvalho CM, Vieira-Coelho MA. Cutaneous endocannabinoid system: Does it have a role on skin wound healing bearing fibrosis? Pharmacol Res 2020;159:104862. [PMID: 32454223 DOI: 10.1016/j.phrs.2020.104862] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
15 Carreira DS, Garden S, Huffman A, Ueland T. Cannabinoids in the Orthopedic Setting: A Literature Review. Orthopedics 2022;:1-7. [PMID: 35245146 DOI: 10.3928/01477447-20220225-11] [Reference Citation Analysis]
16 Laprairie RB, Kulkarni PM, Deschamps JR, Kelly MEM, Janero DR, Cascio MG, Stevenson LA, Pertwee RG, Kenakin TP, Denovan-Wright EM, Thakur GA. Enantiospecific Allosteric Modulation of Cannabinoid 1 Receptor. ACS Chem Neurosci 2017;8:1188-203. [PMID: 28103441 DOI: 10.1021/acschemneuro.6b00310] [Cited by in Crossref: 62] [Cited by in F6Publishing: 57] [Article Influence: 12.4] [Reference Citation Analysis]
17 Rosales-Solano H, Galievsky V, Murtada K, Radovanovic PV, Pawliszyn J. Profiling of Unsaturated Lipids by Raman Spectroscopy Directly on Solid-Phase Microextraction Probes. Anal Chem 2021. [PMID: 34935349 DOI: 10.1021/acs.analchem.1c04054] [Reference Citation Analysis]
18 Towobola A, Towobola B, Nair B, Makwana A. The ethics and management of cannabis use in pregnancy following decriminalisation and licensing for medical use: narrative review. BJPsych Bull 2021;:1-10. [PMID: 34749839 DOI: 10.1192/bjb.2021.102] [Reference Citation Analysis]
19 Mowry FE, Biancardi VC. Neuroinflammation in hypertension: the renin-angiotensin system versus pro-resolution pathways. Pharmacol Res 2019;144:279-91. [PMID: 31039397 DOI: 10.1016/j.phrs.2019.04.029] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 5.7] [Reference Citation Analysis]
20 Moldovan RP, Deuther-Conrad W, Horti AG, Brust P. Synthesis and Preliminary Biological Evaluation of Indol-3-yl-oxoacetamides as Potent Cannabinoid Receptor Type 2 Ligands. Molecules 2017;22:E77. [PMID: 28054997 DOI: 10.3390/molecules22010077] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
21 Kolbe MR, Hohmann T, Hohmann U, Ghadban C, Mackie K, Zöller C, Prell J, Illert J, Strauss C, Dehghani F. THC Reduces Ki67-Immunoreactive Cells Derived from Human Primary Glioblastoma in a GPR55-Dependent Manner. Cancers (Basel) 2021;13:1064. [PMID: 33802282 DOI: 10.3390/cancers13051064] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
22 Feng Z, Liang T, Wang S, Chen M, Hou T, Zhao J, Chen H, Zhou Y, Xie XQ. Binding Characterization of GPCRs-Modulator by Molecular Complex Characterizing System (MCCS). ACS Chem Neurosci 2020;11:3333-45. [PMID: 32941011 DOI: 10.1021/acschemneuro.0c00457] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
23 Murillo-Rodríguez E, Di Marzo V, Machado S, Rocha NB, Veras AB, Neto GAM, Budde H, Arias-Carrión O, Arankowsky-Sandoval G. Role of N-Arachidonoyl-Serotonin (AA-5-HT) in Sleep-Wake Cycle Architecture, Sleep Homeostasis, and Neurotransmitters Regulation. Front Mol Neurosci 2017;10:152. [PMID: 28611585 DOI: 10.3389/fnmol.2017.00152] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.6] [Reference Citation Analysis]
24 Farra YM, Eden MJ, Coleman JR, Kulkarni P, Ferris CF, Oakes JM, Bellini C. Acute neuroradiological, behavioral, and physiological effects of nose-only exposure to vaporized cannabis in C57BL/6 mice. Inhal Toxicol 2020;32:200-17. [PMID: 32475185 DOI: 10.1080/08958378.2020.1767237] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
25 Chen XY, Xue Y, Chen H, Chen L. The globus pallidus as a target for neuropeptides and endocannabinoids participating in central activities. Peptides 2020;124:170210. [PMID: 31778724 DOI: 10.1016/j.peptides.2019.170210] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
26 Datta P, Melkus MW, Rewers-Felkins K, Patel D, Bateman T, Baker T, Hale TW. Human Milk Endocannabinoid Levels as a Function of Obesity and Diurnal Rhythm. Nutrients 2021;13:2297. [PMID: 34371807 DOI: 10.3390/nu13072297] [Reference Citation Analysis]
27 Kratz D, Thomas D, Gurke R. Endocannabinoids as potential biomarkers: It's all about pre-analytics. J Mass Spectrom Adv Clin Lab 2021;22:56-63. [PMID: 34939056 DOI: 10.1016/j.jmsacl.2021.11.001] [Reference Citation Analysis]
28 Páez JA, Campillo NE. Innovative Therapeutic Potential of Cannabinoid Receptors as Targets in Alzheimer’s Disease and Less Well-Known Diseases. CMC 2019;26:3300-40. [DOI: 10.2174/0929867325666180226095132] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
29 MacDonald IJ, Chen YH. The Endocannabinoid System Contributes to Electroacupuncture Analgesia. Front Neurosci 2020;14:594219. [PMID: 33679287 DOI: 10.3389/fnins.2020.594219] [Reference Citation Analysis]
30 Abrams DI, Velasco G, Twelves C, Ganju RK, Bar-Sela G. Cancer Treatment: Preclinical & Clinical. J Natl Cancer Inst Monogr 2021;2021:107-13. [PMID: 34850894 DOI: 10.1093/jncimonographs/lgab010] [Reference Citation Analysis]
31 Ruggiero RN, Rossignoli MT, De Ross JB, Hallak JEC, Leite JP, Bueno-Junior LS. Cannabinoids and Vanilloids in Schizophrenia: Neurophysiological Evidence and Directions for Basic Research. Front Pharmacol 2017;8:399. [PMID: 28680405 DOI: 10.3389/fphar.2017.00399] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
32 Mouhamed Y, Vishnyakov A, Qorri B, Sambi M, Frank SS, Nowierski C, Lamba A, Bhatti U, Szewczuk MR. Therapeutic potential of medicinal marijuana: an educational primer for health care professionals. Drug Healthc Patient Saf 2018;10:45-66. [PMID: 29928146 DOI: 10.2147/DHPS.S158592] [Cited by in Crossref: 18] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
33 Yu JJ, Xue Y, Wang Y, Liu C, Chen L. In vivo Bidirectional Modulation of Cannabinoid on the Activity of Globus Pallidus in Rats. Neuroscience 2021;468:123-38. [PMID: 34129911 DOI: 10.1016/j.neuroscience.2021.06.012] [Reference Citation Analysis]
34 Talukdar A, Maddhesiya P, Namsa ND, Doley R. Snake venom toxins targeting the central nervous system. Toxin Reviews. [DOI: 10.1080/15569543.2022.2084418] [Reference Citation Analysis]
35 Grenier P, Sunavsky A, Olmstead MC. Morphine Induces Upregulation of Neuronally Expressed CB2 Receptors in the Spinal Dorsal Horn of Rats. Cannabis Cannabinoid Res 2021;6:137-47. [PMID: 33912678 DOI: 10.1089/can.2020.0004] [Reference Citation Analysis]
36 Li X, Shen L, Hua T, Liu ZJ. Structural and Functional Insights into Cannabinoid Receptors. Trends Pharmacol Sci 2020;41:665-77. [PMID: 32739033 DOI: 10.1016/j.tips.2020.06.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
37 Aly MW, Ludwig FA, Deuther-Conrad W, Brust P, Abadi AH, Moldovan RP, Osman NA. Development of fluorinated and methoxylated benzothiazole derivatives as highly potent and selective cannabinoid CB2 receptor ligands. Bioorg Chem 2021;114:105191. [PMID: 34375194 DOI: 10.1016/j.bioorg.2021.105191] [Reference Citation Analysis]
38 Kopustinskiene DM, Masteikova R, Lazauskas R, Bernatoniene J. Cannabis sativa L. Bioactive Compounds and Their Protective Role in Oxidative Stress and Inflammation. Antioxidants 2022;11:660. [DOI: 10.3390/antiox11040660] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Dovrtelova G, Zendulka O, Noskova K, Jurica J, Pes O, Dusek J, Carazo A, Zapletalova I, Hlavacova N, Pavek P. Effect of Endocannabinoid Oleamide on Rat and Human Liver Cytochrome P450 Enzymes in In Vitro and In Vivo Models. Drug Metab Dispos 2018;46:913-23. [PMID: 29650790 DOI: 10.1124/dmd.117.079582] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
40 Caillé F, Cacheux F, Peyronneau MA, Jego B, Jaumain E, Pottier G, Ullmer C, Grether U, Winkeler A, Dollé F, Damont A, Kuhnast B. From Structure-Activity Relationships on Thiazole Derivatives to the In Vivo Evaluation of a New Radiotracer for Cannabinoid Subtype 2 PET Imaging. Mol Pharm 2017;14:4064-78. [PMID: 28968497 DOI: 10.1021/acs.molpharmaceut.7b00746] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
41 Saleh N, Hucke O, Kramer G, Schmidt E, Montel F, Lipinski R, Ferger B, Clark T, Hildebrand PW, Tautermann CS. Multiple Binding Sites Contribute to the Mechanism of Mixed Agonistic and Positive Allosteric Modulators of the Cannabinoid CB1 Receptor. Angew Chem Int Ed Engl 2018;57:2580-5. [PMID: 29314474 DOI: 10.1002/anie.201708764] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 7.3] [Reference Citation Analysis]
42 Berman P, Sulimani L, Gelfand A, Amsalem K, Lewitus GM, Meiri D. Cannabinoidomics - An analytical approach to understand the effect of medical Cannabis treatment on the endocannabinoid metabolome. Talanta 2020;219:121336. [PMID: 32887067 DOI: 10.1016/j.talanta.2020.121336] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
43 Demay J, Bernard C, Reinhardt A, Marie B. Natural Products from Cyanobacteria: Focus on Beneficial Activities. Mar Drugs 2019;17:E320. [PMID: 31151260 DOI: 10.3390/md17060320] [Cited by in Crossref: 74] [Cited by in F6Publishing: 43] [Article Influence: 24.7] [Reference Citation Analysis]
44 Tuo W, Bollier M, Leleu-chavain N, Lemaire L, Barczyk A, Dezitter X, Klupsch F, Szczepanski F, Spencer J, Chavatte P, Millet R. Development of novel oxazolo[5,4-d]pyrimidines as competitive CB2 neutral antagonists based on scaffold hopping. European Journal of Medicinal Chemistry 2018;146:68-78. [DOI: 10.1016/j.ejmech.2018.01.034] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
45 Furer T, Nayak K, Shatkin JP. Exploring Interventions for Sleep Disorders in Adolescent Cannabis Users. Med Sci (Basel) 2018;6:E11. [PMID: 29419734 DOI: 10.3390/medsci6010011] [Reference Citation Analysis]
46 Guo X, Ling X, Du F, Wang Q, Huang W, Wang Z, Ding X, Bai M, Wu Z. Molecular Imaging of Pancreatic Duct Adenocarcinoma Using a Type 2 Cannabinoid Receptor-Targeted Near-Infrared Fluorescent Probe. Transl Oncol 2018;11:1065-73. [PMID: 30005208 DOI: 10.1016/j.tranon.2018.06.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
47 Muller C, Reggio PH. An Analysis of the Putative CBD Binding Site in the Ionotropic Cannabinoid Receptors. Front Cell Neurosci 2020;14:615811. [PMID: 33362478 DOI: 10.3389/fncel.2020.615811] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
48 Lynn B, Gee A, Zhang L, Pfaus JG. Effects of Cannabinoids on Female Sexual Function. Sex Med Rev 2020;8:18-27. [PMID: 31521567 DOI: 10.1016/j.sxmr.2019.07.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
49 Habib AM, Okorokov AL, Hill MN, Bras JT, Lee MC, Li S, Gossage SJ, van Drimmelen M, Morena M, Houlden H, Ramirez JD, Bennett DLH, Srivastava D, Cox JJ. Microdeletion in a FAAH pseudogene identified in a patient with high anandamide concentrations and pain insensitivity. Br J Anaesth 2019;123:e249-53. [PMID: 30929760 DOI: 10.1016/j.bja.2019.02.019] [Cited by in Crossref: 43] [Cited by in F6Publishing: 27] [Article Influence: 14.3] [Reference Citation Analysis]
50 Paes-colli Y, Aguiar AFL, Isaac AR, Ferreira BK, Campos RMP, Trindade PMP, de Melo Reis RA, Sampaio LS. Phytocannabinoids and Cannabis-Based Products as Alternative Pharmacotherapy in Neurodegenerative Diseases: From Hypothesis to Clinical Practice. Front Cell Neurosci 2022;16:917164. [DOI: 10.3389/fncel.2022.917164] [Reference Citation Analysis]
51 Lowe H, Toyang N, Steele B, Bryant J, Ngwa W. The Endocannabinoid System: A Potential Target for the Treatment of Various Diseases. Int J Mol Sci 2021;22:9472. [PMID: 34502379 DOI: 10.3390/ijms22179472] [Reference Citation Analysis]
52 Bar-Sela G, Cohen I, Campisi-Pinto S, Lewitus GM, Oz-Ari L, Jehassi A, Peer A, Turgeman I, Vernicova O, Berman P, Wollner M, Moskovitz M, Meiri D. Cannabis Consumption Used by Cancer Patients during Immunotherapy Correlates with Poor Clinical Outcome. Cancers (Basel) 2020;12:E2447. [PMID: 32872248 DOI: 10.3390/cancers12092447] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
53 Bielawiec P, Harasim-Symbor E, Chabowski A. Phytocannabinoids: Useful Drugs for the Treatment of Obesity? Special Focus on Cannabidiol. Front Endocrinol (Lausanne) 2020;11:114. [PMID: 32194509 DOI: 10.3389/fendo.2020.00114] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 8.5] [Reference Citation Analysis]
54 Topuz RD, Gündüz Ö, Karadağ ÇH, Ulugöl A. Non-opioid Analgesics and the Endocannabinoid System. Balkan Med J 2020;37:309-15. [PMID: 32551466 DOI: 10.4274/balkanmedj.galenos.2020.2020.6.66] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
55 Saleh N, Hucke O, Kramer G, Schmidt E, Montel F, Lipinski R, Ferger B, Clark T, Hildebrand PW, Tautermann CS. Multiple Binding Sites Contribute to the Mechanism of Mixed Agonistic and Positive Allosteric Modulators of the Cannabinoid CB1 Receptor. Angew Chem 2018;130:2610-5. [DOI: 10.1002/ange.201708764] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
56 Chiurchiù V, Leuti A, Maccarrone M. Bioactive Lipids and Chronic Inflammation: Managing the Fire Within. Front Immunol 2018;9:38. [PMID: 29434586 DOI: 10.3389/fimmu.2018.00038] [Cited by in Crossref: 140] [Cited by in F6Publishing: 127] [Article Influence: 35.0] [Reference Citation Analysis]
57 Floresta G, Apirakkan O, Rescifina A, Abbate V. Discovery of High-Affinity Cannabinoid Receptors Ligands through a 3D-QSAR Ushered by Scaffold-Hopping Analysis. Molecules 2018;23:E2183. [PMID: 30200181 DOI: 10.3390/molecules23092183] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
58 Lin YF. Potassium channels as molecular targets of endocannabinoids. Channels (Austin) 2021;15:408-23. [PMID: 34282702 DOI: 10.1080/19336950.2021.1910461] [Reference Citation Analysis]
59 Schaffer PC, Kulkarni PM, Janero DR, Thakur GA. Focused structure-activity relationship profiling around the 2-phenylindole scaffold of a cannabinoid type-1 receptor agonist-positive allosteric modulator: site-III aromatic-ring congeners with enhanced activity and solubility. Bioorg Med Chem 2020;28:115727. [PMID: 33065437 DOI: 10.1016/j.bmc.2020.115727] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
60 Hassan AH, Cho MC, Kim HI, Yang JS, Park KT, Hwang JY, Jang C, Park KD, Lee YS. Synthesis of oxidative metabolites of CRA13 and their analogs: Identification of CRA13 active metabolites and analogs thereof with selective CB2R affinity. Bioorganic & Medicinal Chemistry 2018;26:5069-78. [DOI: 10.1016/j.bmc.2018.09.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
61 Bailone RL, Fukushima HCS, de Aguiar LK, Borra RC. The endocannabinoid system in zebrafish and its potential to study the effects of Cannabis in humans. Lab Anim Res 2022;38. [DOI: 10.1186/s42826-022-00116-5] [Reference Citation Analysis]
62 Garai S, Leo LM, Szczesniak AM, Hurst DP, Schaffer PC, Zagzoog A, Black T, Deschamps JR, Miess E, Schulz S, Janero DR, Straiker A, Pertwee RG, Abood ME, Kelly MEM, Reggio PH, Laprairie RB, Thakur GA. Discovery of a Biased Allosteric Modulator for Cannabinoid 1 Receptor: Preclinical Anti-Glaucoma Efficacy. J Med Chem 2021;64:8104-26. [PMID: 33826336 DOI: 10.1021/acs.jmedchem.1c00040] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
63 Ivanov I, Kakularam KR, Shmendel EV, Rothe M, Aparoy P, Heydeck D, Kuhn H. Oxygenation of endocannabinoids by mammalian lipoxygenase isoforms. Biochim Biophys Acta Mol Cell Biol Lipids 2021;1866:158918. [PMID: 33662546 DOI: 10.1016/j.bbalip.2021.158918] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
64 Helcman M, Šmejkal K. Biological activity of Cannabis compounds: a modern approach to the therapy of multiple diseases. Phytochem Rev. [DOI: 10.1007/s11101-021-09777-x] [Reference Citation Analysis]
65 Li LT, Zhao FF, Jia ZM, Qi LQ, Zhang XZ, Zhang L, Li YY, Yang JJ, Wang SJ, Lin H, Liu CH, An DD, Huang YQ, Gao XL. Cannabinoid receptors promote chronic intermittent hypoxia-induced breast cancer metastasis via IGF-1R/AKT/GSK-3β. Mol Ther Oncolytics 2021;23:220-30. [PMID: 34729397 DOI: 10.1016/j.omto.2021.09.007] [Reference Citation Analysis]
66 Garai S, Kulkarni PM, Schaffer PC, Leo LM, Brandt AL, Zagzoog A, Black T, Lin X, Hurst DP, Janero DR, Abood ME, Zimmowitch A, Straiker A, Pertwee RG, Kelly M, Szczesniak AM, Denovan-Wright EM, Mackie K, Hohmann AG, Reggio PH, Laprairie RB, Thakur GA. Application of Fluorine- and Nitrogen-Walk Approaches: Defining the Structural and Functional Diversity of 2-Phenylindole Class of Cannabinoid 1 Receptor Positive Allosteric Modulators. J Med Chem 2020;63:542-68. [PMID: 31756109 DOI: 10.1021/acs.jmedchem.9b01142] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 10.0] [Reference Citation Analysis]
67 Rožanc J, Kotnik P, Milojević M, Gradišnik L, Knez Hrnčič M, Knez Ž, Maver U. Different Cannabis sativa Extraction Methods Result in Different Biological Activities against a Colon Cancer Cell Line and Healthy Colon Cells. Plants (Basel) 2021;10:566. [PMID: 33802757 DOI: 10.3390/plants10030566] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
68 Turna J, Syan SK, Frey BN, Rush B, Costello MJ, Weiss M, MacKillop J. Cannabidiol as a Novel Candidate Alcohol Use Disorder Pharmacotherapy: A Systematic Review. Alcohol Clin Exp Res 2019;43:550-63. [PMID: 30698831 DOI: 10.1111/acer.13964] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 9.7] [Reference Citation Analysis]
69 Bononi G, Tonarini G, Poli G, Barravecchia I, Caligiuri I, Macchia M, Rizzolio F, Demontis GC, Minutolo F, Granchi C, Tuccinardi T. Monoacylglycerol lipase (MAGL) inhibitors based on a diphenylsulfide-benzoylpiperidine scaffold. Eur J Med Chem 2021;223:113679. [PMID: 34218085 DOI: 10.1016/j.ejmech.2021.113679] [Reference Citation Analysis]
70 Galán-Ganga M, Rodríguez-Cueto C, Merchán-Rubira J, Hernández F, Ávila J, Posada-Ayala M, Lanciego JL, Luengo E, Lopez MG, Rábano A, Fernández-Ruiz J, Lastres-Becker I. Cannabinoid receptor CB2 ablation protects against TAU induced neurodegeneration. Acta Neuropathol Commun 2021;9:90. [PMID: 34001284 DOI: 10.1186/s40478-021-01196-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
71 Huang D, Zhang B, Han T, Liu G, Chen X, Zhao Z, Feng J, Yang J, Wang T. Genome-wide prediction and comparative transcriptomic analysis reveals the G protein-coupled receptors involved in gonadal development of Apostichopus japonicus. Genomics 2021;113:967-78. [PMID: 33144216 DOI: 10.1016/j.ygeno.2020.10.030] [Reference Citation Analysis]
72 Safavynia SA, Goldstein PA. The Role of Neuroinflammation in Postoperative Cognitive Dysfunction: Moving From Hypothesis to Treatment. Front Psychiatry 2018;9:752. [PMID: 30705643 DOI: 10.3389/fpsyt.2018.00752] [Cited by in Crossref: 49] [Cited by in F6Publishing: 45] [Article Influence: 16.3] [Reference Citation Analysis]
73 Namba MD, Tomek SE, Olive MF, Beckmann JS, Gipson CD. The Winding Road to Relapse: Forging a New Understanding of Cue-Induced Reinstatement Models and Their Associated Neural Mechanisms. Front Behav Neurosci 2018;12:17. [PMID: 29479311 DOI: 10.3389/fnbeh.2018.00017] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
74 Lipnik-Štangelj M, Razinger B. A regulatory take on cannabis and cannabinoids for medicinal use in the European Union. Arh Hig Rada Toksikol 2020;71:12-8. [PMID: 32597142 DOI: 10.2478/aiht-2020-71-3302] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
75 Castaneda JT, Harui A, Roth MD. Regulation of Cell Surface CB2 Receptor during Human B Cell Activation and Differentiation. J Neuroimmune Pharmacol 2017;12:544-54. [PMID: 28364261 DOI: 10.1007/s11481-017-9744-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
76 Gotfried J, Kataria R, Schey R. Review: The Role of Cannabinoids on Esophageal Function-What We Know Thus Far. Cannabis Cannabinoid Res 2017;2:252-8. [PMID: 29098187 DOI: 10.1089/can.2017.0031] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
77 Kratz D, Sens A, Schäfer SMG, Hahnefeld L, Geisslinger G, Thomas D, Gurke R. Pre-analytical challenges for the quantification of endocannabinoids in human serum. J Chromatogr B Analyt Technol Biomed Life Sci 2022;1190:123102. [PMID: 35026652 DOI: 10.1016/j.jchromb.2022.123102] [Reference Citation Analysis]